An analysis of the registration and approvals for class Ⅰ of innovative drug during 2005-2016 in China
FAN Yu-lu
CHEN Yu-wen
Abstract：This paper indexed the registrations and applications of all class Ⅰ of innovative drugs during 2005-2016 through database,and analyzed their amounts,indications and conclusions of approval.The results showed that the number of class Ⅰ of innovative drug in China was 855 during 2005-2016,32 was approved and the approval rate was only 3.76％.The categories of innovative drug are focused on the area of anti-tumor and antiinfection.Therefore,innovative drugs should not only have new structures,but also meet clinical requirements.
Keywords：class Ⅰ of innovative drugnew drug research and developmentdrug registrationretrospective analysis
Publication Date：2018-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 142-146 )